fda shortage tirzepatide π¨ Alert: No Longer on FDA's Drug List As of October 2, 2024, the has announced that the Tirzepatide shortage has been resolved. This means that all doses of FDA Declares End to Tirzepatide
Description
When I grew up in Finland, the steroid era was in full swing
That's deliberate

Long-term GLP-1 medication use shows cardiovascular benefits in trials, but emerging data on bone health and pancreatitis risk requires ongoing monitoring

A class action lawsuit accuses Kourtney Kardashian's Lemme supplement brand of misleading consumers with false weight-loss claims for its GLP-1 Daily gummies.

Notably, the combination preserved lean mass while reducing visceral fat, highlighting its potential for effective obesity management.